Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes
Objective: Type 2 diabetes (T2D) is a risk factor for cognitive impairment and cerebral small vessel disease (CSVD). The relation of metformin use and cognitive impairment or CSVD is not clear. The objective of this study was to investigate the cross-sectional effects of long-term use of metformin o...
Main Authors: | Zhenjie Teng, Jing Feng, Qianqian Qi, Yanhong Dong, Yining Xiao, Xiaohua Xie, Nan Meng, Huifang Chen, Wenhui Zhang, Peiyuan Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.773797/full |
Similar Items
-
Triglyceride glucose index is associated with cerebral small vessel disease burden and cognitive impairment in elderly patients with type 2 diabetes mellitus
by: Zhenjie Teng, et al.
Published: (2022-08-01) -
Cerebral small vessel disease mediates the association between homocysteine and cognitive function
by: Zhenjie Teng, et al.
Published: (2022-07-01) -
Retinal thickness changes in different subfields reflect the volume change of cerebral white matter hyperintensity
by: Xiaohan Lv, et al.
Published: (2022-10-01) -
Systemic Immune-Inflammation Index is Associated with Cerebral Small Vessel Disease Burden and Cognitive Impairment
by: Xiao Y, et al.
Published: (2023-02-01) -
A Nomogram Including Total Cerebral Small Vessel Disease Burden Score for Predicting Mild Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
by: Teng Z, et al.
Published: (2024-04-01)